RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: multiple sclerosis
Accession: DOID:2377
browse the term
Definition: A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring. (DO)
Synonyms: exact_synonym: MS; MS (Multiple Sclerosis); acute fulminating multiple sclerosis; disseminated sclerosis; generalized multiple sclerosis; insular sclerosis
related_synonym: MS1; MS2; MS3; MS4; MS5; multiple sclerosis modifier of disease progression; multiple sclerosis, susceptibility to; multiple sclerosis, susceptibility to, 1; multiple sclerosis, susceptibility to, 2; multiple sclerosis, susceptibility to, 3; multiple sclerosis, susceptibility to, 4; multiple sclerosis, susceptibility to, 5
primary_id: MESH:D009103
alt_id: OMIM:126200 ; OMIM:612594 ; OMIM:612595 ; OMIM:612596 ; OMIM:614810
xref: EFO:0003885 ; GARD:10255 ; ICD10CM:G35 ; ICD9CM:340 ; MONDO:0005301 ; NCI:C3243 ; OMIM:PS126200
For additional species annotation, visit the
Alliance of Genome Resources .
G
A2M
alpha-2-macroglobulin
IAGP
RGD
PMID:11498265
RGD:1549857
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
ACAN
aggrecan
IEP
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr15:88,803,436...88,875,353
Ensembl chr15:88,803,436...88,875,353
G
ACHE
acetylcholinesterase (Yt blood group)
IEP
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
IAGP
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGT
angiotensinogen
IEP
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AIM2
absent in melanoma 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:159,055,051...159,147,132
Ensembl chr 1:159,061,599...159,187,843
G
APOA1
apolipoprotein A1
IEP
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
APOC2
apolipoprotein C2
IAGP
RGD
PMID:10335523
RGD:1358408
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
G
APOE
apolipoprotein E
IEA EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896 PMID:15118671
RGD:1331525
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
B4GALT5
beta-1,4-galactosyltransferase 5
IEP
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr20:49,632,945...49,713,878
Ensembl chr20:49,632,945...49,713,878
G
B4GALT6
beta-1,4-galactosyltransferase 6
IEP
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr18:31,622,246...31,724,641
Ensembl chr18:31,622,246...31,685,836
G
BCHE
butyrylcholinesterase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
BCL2L2
BCL2 like 2
IEP
mRNA:decreased expression:brain:
RGD
PMID:24270187
RGD:14394512
NCBI chr14:23,306,833...23,311,751
Ensembl chr14:23,298,790...23,311,751
G
BDNF
brain derived neurotrophic factor
onset
IEP
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CACNA1B
calcium voltage-gated channel subunit alpha1 B
IEP
RGD
PMID:11353727
RGD:1580151
NCBI chr 9:137,877,782...138,124,619
Ensembl chr 9:137,877,782...138,124,624
G
CASP1
caspase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CAV1
caveolin 1
IAGP
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
G
CBLB
Cbl proto-oncogene B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
G
CCL1
C-C motif chemokine ligand 1
IAGP
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
G
CCL13
C-C motif chemokine ligand 13
IAGP
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
G
CCL2
C-C motif chemokine ligand 2
IAGP
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL5
C-C motif chemokine ligand 5
IEP
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL7
C-C motif chemokine ligand 7
IEP IAGP
mRNA,protein:increased expression:brain DNA:polymorphism:promoter
RGD
PMID:9655469 PMID:12127674
RGD:6483814 , RGD:6483818
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCR3
C-C motif chemokine receptor 3
IEP
RGD
PMID:21427490
RGD:6892919
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CCR5
C-C motif chemokine receptor 5
IAGP IEP
DNA:frameshift mutation:CDS:p.S185_T195del (rs333) (human) ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression protein:increased expression:blood, cerebrospinal fluid
ClinVar RGD
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 PMID:12451219 PMID:12111306 More...
RGD:1358460 , RGD:8551829
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CCR5AS
CCR5 antisense RNA
IAGP
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 More...
NCBI chr 3:46,363,984...46,407,066
Ensembl chr 3:46,364,391...46,407,117
G
CD24
CD24 molecule
IAGP
RGD
PMID:14657362
RGD:1358462
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CD28
CD28 molecule
IAGP
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,475...203,738,912
G
CD40
CD40 molecule
susceptibility
IAGP EXP
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human)
CTD RGD
PMID:19525955 PMID:20634952 PMID:20190274
RGD:5490971 , RGD:5490975
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD44
CD44 molecule (IN blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CD46
CD46 molecule
IDA
RGD
PMID:21177319
RGD:6483460
NCBI chr 1:207,752,038...207,795,516
Ensembl chr 1:207,752,037...207,795,513
G
CD58
CD58 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955 PMID:24076602
NCBI chr 1:116,514,534...116,571,026
Ensembl chr 1:116,514,534...116,571,039
G
CD6
CD6 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr11:60,971,680...61,020,377
Ensembl chr11:60,971,680...61,020,377
G
CD86
CD86 molecule
susceptibility
IAGP
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CD96
CD96 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:111,542,197...111,665,996
Ensembl chr 3:111,292,719...111,665,750
G
CDK17
cyclin dependent kinase 17
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr12:96,278,225...96,400,439
Ensembl chr12:96,278,261...96,400,480
G
CFH
complement factor H
no_association
IEP
RGD
PMID:21618592
RGD:5684555
NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
G
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
IAGP
DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:-168A>G DNA:polymorphism:promoter:rs3087456, no association in a German cohort
RGD
PMID:21653641 PMID:15821736 PMID:16426246
RGD:5491175 , RGD:1358146 , RGD:5491189
NCBI chr16:10,866,206...10,943,021
Ensembl chr16:10,866,222...10,943,021
G
CLDN11
claudin 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr 3:170,418,868...170,434,691
Ensembl chr 3:170,418,868...170,454,733
G
CLEC16A
C-type lectin domain containing 16A
IAGP EXP
DNA:polymorphism:intron:g.194570G>A, rs7184083 CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr16:10,944,564...11,182,186
Ensembl chr16:10,944,539...11,182,186
G
CMAHP
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:25,081,067...25,138,392
Ensembl chr 6:25,081,862...25,138,081
G
CMPK2
cytidine/uridine monophosphate kinase 2
IEP
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
IEP IDA
RGD
PMID:19473295 PMID:18676363
RGD:6483339 , RGD:6483346
NCBI chr17:41,966,795...41,977,740
Ensembl chr17:41,966,763...41,977,740
G
CNR1
cannabinoid receptor 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
CNTF
ciliary neurotrophic factor
onset
IAGP
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chr11:58,622,665...58,625,733
Ensembl chr11:58,622,665...58,625,733
G
COL1A1
collagen type I alpha 1 chain
IEP
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
CST3
cystatin C
ISO IEP
protein:decreased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:12589965
RGD:5686392 , RGD:5686394
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association
IAGP
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:17942509 PMID:19740340 PMID:10082437
RGD:2301975 , RGD:7411672 , RGD:1358538
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CTSB
cathepsin B
ISO IEP
protein:increased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:11134381
RGD:5686392 , RGD:5686395
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CTSH
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr15:78,921,058...78,945,046
Ensembl chr15:78,921,058...78,949,574
G
CTSL
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CXCL8
C-X-C motif chemokine ligand 8
IEP
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
IAGP
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868
NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986
G
DNAAF11
dynein axonemal assembly factor 11
IAGP
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 8:132,570,416...132,702,913
Ensembl chr 8:132,570,416...132,675,592
G
DUSP28
dual specificity phosphatase 28
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:240,560,054...240,565,256
Ensembl chr 2:240,560,054...240,565,256
G
EDN1
endothelin 1
IEP
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
ERN1
endoplasmic reticulum to nucleus signaling 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
G
FAS
Fas cell surface death receptor
susceptibility
IEP IAGP
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 , RGD:12903986
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
IAGP EXP
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31068361 PMID:11438180
RGD:1358622
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FCGR2A
Fc gamma receptor IIa
no_association
IAGP
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FCGR3A
Fc gamma receptor IIIa
disease_progression
IEP
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
IAGP
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:152,166,234...152,451,315
Ensembl chr X:152,166,234...152,451,315
G
GC
GC vitamin D binding protein
susceptibility no_association
IAGP EXP IEP
CTD Direct Evidence: marker/mechanism protein:decreased expression:cerebrospinal fluid protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human)
CTD RGD
PMID:25590278 PMID:12137326 PMID:18807170 PMID:19324981 PMID:12044990
RGD:5509885 , RGD:5509923 , RGD:5509922 , RGD:5509887
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GLI1
GLI family zinc finger 1
IEP
RGD
PMID:18991353
RGD:12801440
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
G
GRM8
glutamate metabotropic receptor 8
IEP
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr 7:126,438,598...127,252,941
Ensembl chr 7:126,438,598...127,253,093
G
GRN
granulin precursor
IEP
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
G
GSTM1
glutathione S-transferase mu 1
disease_progression susceptibility onset
IAGP
DNA:deletion: : DNA:deletion: : (human) DNA:deletion:: (human)
RGD
PMID:10680782 PMID:17437619 PMID:23932298
RGD:5490267 , RGD:12792249 , RGD:12792225
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM3
glutathione S-transferase mu 3
disease_progression
IAGP
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
GSTP1
glutathione S-transferase pi 1
disease_progression
IAGP
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
no_association
IAGP
DNA:deletion:: (human)
RGD
PMID:23932298 PMID:10680782
RGD:12792225 , RGD:5490267
G
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
IAGP
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr 1:9,234,774...9,271,337
Ensembl chr 1:9,234,774...9,271,337
G
HDAC1
histone deacetylase 1
IEP
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human) DNA:polymorphism: :HLA-DPB1*0501 (human)
CTD RGD
PMID:17956852 PMID:32560041 PMID:17125797
RGD:150429806 , RGD:150429801
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:polymorphism (human)
RGD
PMID:21741664
RGD:5147555
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP EXP
DNA:polymorphism (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:cds:HLA-DQB1*0301 (human) DNA:polymorphism:cds:HLA-DQB1*06 (human)
OMIM CTD RGD
PMID:21741664 PMID:15201511 PMID:21908482 PMID:20463743
RGD:5147555 , RGD:40818409 , RGD:7421588 , RGD:5147658
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRA
major histocompatibility complex, class II, DR alpha
IAGP EXP
DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human) DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human)
CTD RGD
PMID:17660530 PMID:17660530 PMID:10527398 PMID:19834503
RGD:5490159 , RGD:5490204 , RGD:5490202
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility onset
IAGP EXP
DNA:polymorphism: :HLA-DRB*1501 (human) ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to DNA:polymorphism:cds:HLA-DRB1*1302 (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :multiple (human) DNA:polymorphism: :HLA-DRB1*0801 (human) DNA:polymorphisms: :HLA-DRB1*11, HLA-DRB1*15 (human)
ClinVar OMIM CTD RGD
PMID:25741868 PMID:25911099 PMID:21741664 PMID:15201511 PMID:20207784 PMID:20580995 PMID:21440682 PMID:21664963 More...
RGD:5147555 , RGD:40818409 , RGD:5147580 , RGD:5147573 , RGD:5147564 , RGD:5147559
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HLA-DRB3
major histocompatibility complex, class II, DR beta 3
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DRB3*0202, *0301 (human)
RGD
PMID:15201511
RGD:40818409
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
IDA
RGD
PMID:14688203
RGD:5686803
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
G
HSPA8
heat shock protein family A (Hsp70) member 8
IEP
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
ICAM1
intercellular adhesion molecule 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNB1
interferon beta 1
treatment
EXP IDA
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:23517930 PMID:27806875 PMID:15389896 More...
RGD:401854232
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
G
IFNG
interferon gamma
susceptibility
IAGP EXP
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:9818947
RGD:1358738
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGF2
insulin like growth factor 2
IEP
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
IL10
interleukin 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12A
interleukin 12A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
IL13
interleukin 13
severity
IEP
protein:increased expression:serum protein:increased expression:cerebrospinal fluid
RGD
PMID:22031307 PMID:21677024
RGD:5684368 , RGD:8549589
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL17A
interleukin 17A
IEP EXP
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:21455110
RGD:8698672
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1B
interleukin 1 beta
severity
IAGP EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15210533 PMID:25458313 PMID:10025794
RGD:1358741
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL21R
interleukin 21 receptor
IAGP IEP
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 , RGD:6892963
NCBI chr16:27,402,174...27,452,042
Ensembl chr16:27,402,174...27,452,042
G
IL23R
interleukin 23 receptor
no_association
IAGP
DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human) DNA:SNPs: :rs2201841,rs10889677,s7517847(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 , RGD:8549632
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
IL2RA
interleukin 2 receptor subunit alpha
IAGP EXP
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17660530 PMID:19119414 PMID:19525955 PMID:24076602 PMID:19125193
RGD:2311526
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
IL32
interleukin 32
IEP
protein:increased expression:blood plasma (human)
RGD
PMID:23180362
RGD:150340728
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
IL4
interleukin 4
onset
IAGP
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
IAGP
RGD
PMID:14712310
RGD:4890395
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
severity treatment
IAGP IDA
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:12791288 , RGD:12792202 , RGD:11079567
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL7
interleukin 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
G
IL7R
interleukin 7 receptor
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
CTD ClinVar
PMID:17660530 PMID:17660816 PMID:17660817 PMID:19525955 PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
G
IRF5
interferon regulatory factor 5
susceptibility
IDA IAGP
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:25392335 PMID:20861862
RGD:11055911 , RGD:40924643
NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038
G
IRF8
interferon regulatory factor 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606
G
JAG1
jagged canonical Notch ligand 1
disease_progression
IEP IAGP
RGD
PMID:20805994 PMID:16934875
RGD:6482233 , RGD:6482240
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
G
JARID2
jumonji and AT-rich interaction domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:15,246,069...15,522,042
Ensembl chr 6:15,246,069...15,522,042
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr 1:160,037,467...160,070,160
Ensembl chr 1:159,998,651...160,070,483
G
KIF1B
kinesin family member 1B
susceptibility no_association
IAGP EXP
DNA:snp:intron:c.1590+932T>C (rs10492972) (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18997785 PMID:18997785 PMID:20502484
RGD:12738462 , RGD:12738463
NCBI chr 1:10,210,570...10,381,603
Ensembl chr 1:10,210,570...10,381,603
G
KIF5A
kinesin family member 5A
susceptibility
IAGP
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr12:57,550,044...57,586,633
Ensembl chr12:57,546,026...57,586,633
G
KLHL6
kelch like family member 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:183,487,551...183,555,706
Ensembl chr 3:183,487,551...183,555,706
G
KLK6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr19:50,958,631...50,969,591
Ensembl chr19:50,958,631...50,969,673
G
LRCH1
leucine rich repeats and calponin homology domain containing 1
ISS
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr13:46,553,170...46,753,041
Ensembl chr13:46,553,168...46,753,040
G
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:89,615,824...89,719,533
Ensembl chr 1:89,633,072...89,769,903
G
MAG
myelin associated glycoprotein
IEP
RGD
PMID:2419505
RGD:9685292
NCBI chr19:35,292,161...35,313,807
Ensembl chr19:35,292,125...35,313,807
G
MBP
myelin basic protein
IAGP
RGD
PMID:1691612
RGD:1358488
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
G
MCAM
melanoma cell adhesion molecule
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr11:119,308,529...119,317,130
Ensembl chr11:119,308,529...119,321,521
G
MMP12
matrix metallopeptidase 12
susceptibility
IAGP
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMP9
matrix metallopeptidase 9
no_association susceptibility
IEP IAGP
mRNA:increased expression:blood, mononuclear cell DNA:SNP, repeat:promoter:-1562C>T (human) DNA:repeat, SNP:promoter DNA:SNP:promoter:-1562C>T (human)
RGD
PMID:23401127 PMID:20471697 PMID:10713364 PMID:19628284
RGD:13204754 , RGD:13204848 , RGD:13204826 , RGD:13204795
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MOG
myelin oligodendrocyte glycoprotein
IDA
RGD
PMID:17142321
RGD:9685374
NCBI chr 6:29,657,092...29,672,365
Ensembl chr 6:29,657,002...29,672,372
G
MPHOSPH9
M-phase phosphoprotein 9
susceptibility
IAGP
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr12:123,152,324...123,244,002
Ensembl chr12:123,152,320...123,244,014
G
MT-ATP6
mitochondrially encoded ATP synthase membrane subunit 6
IAGP
DNA:transition:cds:m.9055A>G (human) DNA:point mutations: :m.8697G>A, m.8684C>T, m.8856G>A (human)
RGD
PMID:18708297 PMID:17619138
RGD:5490259 , RGD:5490263
NCBI chr MT:8,527...9,207
Ensembl chr MT:8,527...9,207
G
MT-ATP8
mitochondrially encoded ATP synthase membrane subunit 8
IAGP
DNA:point mutation: :m.8406C>T (human)
RGD
PMID:17619138
RGD:5490263
NCBI chr MT:8,366...8,572
Ensembl chr MT:8,366...8,572
G
MT-ND1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
IEP
DNA:amplification:cds:cerebral gray matter (human)
RGD
PMID:18566918
RGD:5490252
NCBI chr MT:3,307...4,262
Ensembl chr MT:3,307...4,262
G
MT-ND2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
IAGP
DNA:SNP::m.4917A>G
RGD
PMID:18708297
RGD:5490259
NCBI chr MT:4,470...5,511
Ensembl chr MT:4,470...5,511
G
NABP1
nucleic acid binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:191,678,136...191,686,943
Ensembl chr 2:191,678,068...191,741,097
G
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
IAGP
RGD
PMID:18682780
RGD:6482255
NCBI chr 1:161,197,417...161,214,395
Ensembl chr 1:161,197,104...161,214,723
G
NECTIN2
nectin cell adhesion molecule 2
severity no_association
IAGP EXP
DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:16738668 PMID:16738668 PMID:17376543
RGD:6767558 , RGD:6767565
NCBI chr19:44,846,297...44,889,223
Ensembl chr19:44,846,175...44,889,223
G
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:11,183,298...11,382,348
Ensembl chr 6:11,183,298...11,382,348
G
NEFH
neurofilament heavy chain
severity
IEP
RGD
PMID:16764346
RGD:27226808
NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
G
NEFL
neurofilament light chain
disease_progression
IEP
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 , RGD:127285024
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
NGFR
nerve growth factor receptor
IEP
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NLRP3
NLR family pyrin domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NONO
non-POU domain containing octamer binding
HEP
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:71,283,635...71,301,168
Ensembl chr X:71,254,814...71,301,522
G
NOTCH4
notch receptor 4
IAGP
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
G
NR1H3
nuclear receptor subfamily 1 group H member 3
IAGP
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
P2RX7
purinergic receptor P2X 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr12:121,132,876...121,188,032
Ensembl chr12:121,132,819...121,188,032
G
PDCD1
programmed cell death 1
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12402038 PMID:15912506
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
PHACTR2
phosphatase and actin regulator 2
IAGP
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr 6:143,536,878...143,831,185
Ensembl chr 6:143,536,845...143,831,185
G
PLA2G7
phospholipase A2 group VII
IEP
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PNMT
phenylethanolamine N-methyltransferase
IAGP
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr17:39,668,019...39,670,475
Ensembl chr17:39,667,981...39,670,475
G
POLG
DNA polymerase gamma, catalytic subunit
IAGP
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
G
POMC
proopiomelanocortin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
PRF1
perforin 1
ISO ISS IAGP IEP
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) protein:increased expression:blood, T cell
MouseDO RGD
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 , RGD:6482820 , RGD:6482817
NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759
G
PRKN
parkin RBR E3 ubiquitin protein ligase
IEP
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
PRNP
prion protein (Kanno blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
G
PSMB9
proteasome 20S subunit beta 9
IAGP
RGD
PMID:20174631
RGD:6483446
NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,859,851
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
IAGP
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
PTPRC
protein tyrosine phosphatase receptor type C
IAGP
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,757,476
G
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
G
RGMA
repulsive guidance molecule BMP co-receptor a
IAGP
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr15:93,035,271...93,089,211
Ensembl chr15:93,035,271...93,089,211
G
RHOA
ras homolog family member A
IEP
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
RNF19A
ring finger protein 19A, RBR E3 ubiquitin protein ligase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 8:100,257,067...100,336,204
Ensembl chr 8:100,257,060...100,336,218
G
RNF217
ring finger protein 217
IAGP
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr 6:124,962,437...125,092,634
Ensembl chr 6:124,962,437...125,092,633
G
SELE
selectin E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
G
SH2D2A
SH2 domain containing 2A
susceptibility
IAGP
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:11528519 PMID:18554728
RGD:1358573 , RGD:2298871
NCBI chr 1:156,806,243...156,816,848
Ensembl chr 1:156,806,243...156,816,848
G
SHH
sonic hedgehog signaling molecule
IEP
RGD
PMID:18991353
RGD:12801440
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
SLC11A1
solute carrier family 11 member 1
no_association
IAGP EXP
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human)
CTD RGD
PMID:16597321 PMID:18973068 PMID:15584484
RGD:5684937 , RGD:5684960
NCBI chr 2:218,382,273...218,396,894
Ensembl chr 2:218,382,029...218,396,894
G
SPP1
secreted phosphoprotein 1
IAGP IDA
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:15885319 PMID:11721059
RGD:1581472 , RGD:1581329
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
STAT4
signal transducer and activator of transcription 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
SYS1
SYS1 golgi trafficking protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:45,361,949...45,376,798
Ensembl chr20:45,361,937...45,376,798
G
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
IAGP
DNA:synonymous mutation: : DNA:SNPs:CDs:p.V379I, A565T(human)
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 , RGD:6482281 , RGD:6482280
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
TLR4
toll like receptor 4
IEP
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
disease_progression no_association
IEP ISS IAGP
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
MouseDO RGD
PMID:8964914 PMID:9270614 PMID:8887999
RGD:7401237 , RGD:12904657 , RGD:12904068
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP3
TNF alpha induced protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
IAGP EXP
DNA:SNP:intron: (rs1800693) (human) ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:19525953 PMID:22801493 PMID:24033266 PMID:24076602 PMID:25741868 PMID:28492532 PMID:22801493 More...
RGD:8661741
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFSF14
TNF superfamily member 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr19:6,661,253...6,670,588
Ensembl chr19:6,661,253...6,670,588
G
TNFSF9
TNF superfamily member 9
IEP
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr19:6,531,026...6,535,924
Ensembl chr19:6,531,026...6,535,924
G
TRAF1
TNF receptor associated factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
G
TYK2
tyrosine kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,533...10,380,608
G
VCAM1
vascular cell adhesion molecule 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VDR
vitamin D receptor
no_association susceptibility
TAS EXP IAGP IEA
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human) DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human)
CTD RGD
PMID:25853421 PMID:15118671 PMID:27049563 PMID:25685788 PMID:26540116 PMID:21664963 PMID:15118671 More...
RGD:1331525 , RGD:11530654 , RGD:13210790 , RGD:11353119 , RGD:5147559 , RGD:1331525
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
VHL
von Hippel-Lindau tumor suppressor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:10,141,778...10,153,667
Ensembl chr 3:10,141,778...10,153,667
G
XBP1
X-box binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
G
ZNF267
zinc finger protein 267
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr16:31,873,807...31,917,357
Ensembl chr16:31,873,807...31,917,357
G
AQP4
aquaporin 4
IDA
RGD
PMID:17468440
RGD:8698645
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
IAGP
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:70,672,506...70,762,441
Ensembl chr10:70,672,506...70,762,441
G
BCHE
butyrylcholinesterase
IEP
RGD
PMID:20122907
RGD:5687690
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
CD274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
GC
GC vitamin D binding protein
IEP
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GRN
granulin precursor
susceptibility
IEP IAGP
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:21613335 PMID:20463744
RGD:5509591 , RGD:5509596
NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
severity
IAGP
DNA:polymorphism: :HLA-DQB1*0602 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
severity
IAGP
DNA:polymorphisms, haplotype: :HLA-DR2, HLA-DRB1*1501 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
IAGP
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
G
IGFBP3
insulin like growth factor binding protein 3
disease_progression
IEP
RGD
PMID:15732261
RGD:1626118
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IL4R
interleukin 4 receptor
IAGP
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
MMP9
matrix metallopeptidase 9
IEP
RGD
PMID:14504963
RGD:13204808
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
POLG
DNA polymerase gamma, catalytic subunit
IAGP
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
G
POLGARF
POLG alternative reading frame
IAGP
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,330,208...89,333,809
G
SHH
sonic hedgehog signaling molecule
IEP
RGD
PMID:12926841
RGD:12801414
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
ACKR3
atypical chemokine receptor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354
G
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
IAGP
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:70,672,506...70,762,441
Ensembl chr10:70,672,506...70,762,441
G
APOA4
apolipoprotein A4
onset
IEP
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOE
apolipoprotein E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
CD36
CD36 molecule (CD36 blood group)
IEP
RGD
PMID:20855355
RGD:6893496
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD80
CD80 molecule
IEP
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CSPG4
chondroitin sulfate proteoglycan 4
IDA
RGD
PMID:10976643
RGD:5686865
NCBI chr15:75,674,322...75,713,466
Ensembl chr15:75,674,322...75,712,848
G
CTSS
cathepsin S
IEP
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
G
FAS
Fas cell surface death receptor
susceptibility
IAGP
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
GRN
granulin precursor
disease_progression
IEP
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
G
HAVCR1
hepatitis A virus cellular receptor 1
IEP
RGD
PMID:15153541
RGD:5128853
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
IAGP
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
G
HSPA8
heat shock protein family A (Hsp70) member 8
IEP
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
KLC1
kinesin light chain 1
susceptibility
IAGP
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr14:103,629,211...103,701,544
Ensembl chr14:103,561,896...103,714,249
G
MMP19
matrix metallopeptidase 19
IEP
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr12:55,835,433...55,842,936
Ensembl chr12:55,835,433...55,842,966
G
MMP9
matrix metallopeptidase 9
treatment
IEP
RGD
PMID:16412833
RGD:13204825
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NEFH
neurofilament heavy chain
treatment
IEP
RGD
PMID:15222692
RGD:27226879
NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
G
NEFL
neurofilament light chain
IEP
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 , RGD:127285027
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
NOD2
nucleotide binding oligomerization domain containing 2
disease_progression
IAGP
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
NOG
noggin
IEP
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr17:56,593,699...56,595,611
Ensembl chr17:56,593,699...56,595,611
G
S100B
S100 calcium binding protein B
IEP
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
SERPINE1
serpin family E member 1
disease_progression
IEP
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
TIMP1
TIMP metallopeptidase inhibitor 1
treatment
IEP
RGD
PMID:16412833
RGD:13204825
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
IAGP
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all